Compare Novartis AG (NVS) vs Tidewater Inc (TDW) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Novartis AG vs Tidewater Inc — how do they compare? Novartis AG trades at $152.38 (market cap $295.37B), while Tidewater Inc trades at $91 (market cap $4.54B). The key difference: Novartis AG is far larger — about 65.1× Tidewater Inc's market cap, and Novartis AG pays a 3.07% dividend while Tidewater Inc pays none. Which is the better fit depends on your goals.
| NVS | TDW | |
|---|---|---|
Market Cap | $295.37B | $4.54B |
Sector | Health | Utilities |
52-Week High | $168.62 | $91.20 |
52-Week Low | $119.31 | $47.29 |
Enterprise Value | $336.69B | $4.58B |
Dividend Yield | 3.07% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Novartis AG
Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
Read more on NVS →About Tidewater Inc
Tidewater is the leading global provider of offshore support vessels (OSVs) to the energy industry. With the world's largest fleet of platform supply vessels (PSVs) and anchor handling tugs (AHTS), it provides critical logistics and marine support for offshore oil, gas, and renewable energy projects. Following a period of massive strategic consolidation, Tidewater is now focused on maximizing day rates and free cash flow in a supply-constrained market, positioning itself as a primary beneficiary of the multi-year offshore upcycle.
Read more on TDW →
